{"id":"https://openalex.org/W2168397227","doi":"https://doi.org/10.1136/ard.2008.088401","title":"Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis","display_name":"Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis","publication_year":2008,"publication_date":"2008-04-30","ids":{"openalex":"https://openalex.org/W2168397227","doi":"https://doi.org/10.1136/ard.2008.088401","mag":"2168397227","pmid":"https://pubmed.ncbi.nlm.nih.gov/18445623"},"language":"en","primary_location":{"id":"doi:10.1136/ard.2008.088401","doi":"https://doi.org/10.1136/ard.2008.088401","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.2008.088401","pdf_url":"https://ard.bmj.com/content/annrheumdis/68/4/558.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/68/4/558.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007969949","display_name":"Wouter H Bos","orcid":"https://orcid.org/0000-0003-3720-793X","observed_orcids":["https://orcid.org/0000-0003-3720-793X"]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"W H Bos","raw_affiliation_strings":["Sanquin Research, Amsterdam, The Netherlands. w.bos@sanquin.nl","Department of Immunopathology, Sanquin Research, PO Box 9190, 1006 AD Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanquin Research, Amsterdam, The Netherlands. w.bos@sanquin.nl","institution_ids":["https://openalex.org/I3020210244"]},{"raw_affiliation_string":"Department of Immunopathology, Sanquin Research, PO Box 9190, 1006 AD Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090033299","display_name":"G. M. Bartelds","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G M Bartelds","raw_affiliation_strings":["Jan van Breemen Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jan van Breemen Institute, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048956254","display_name":"Marijn Vis","orcid":"https://orcid.org/0000-0002-4402-4165","observed_orcids":["https://orcid.org/0000-0002-4402-4165"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M Vis","raw_affiliation_strings":["VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086505825","display_name":"Ann R. van der Horst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A R van der Horst","raw_affiliation_strings":["Sanquin Diagnostic Services, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanquin Diagnostic Services, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029733252","display_name":"Gertjan Wolbink","orcid":"https://orcid.org/0000-0003-1924-7460","observed_orcids":["https://orcid.org/0000-0003-1924-7460"]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"G J Wolbink","raw_affiliation_strings":["Jan van Breemen Institute, Amsterdam, The Netherlands","Sanquin Research, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jan van Breemen Institute, Amsterdam, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"Sanquin Research, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109954825","display_name":"Rob J. van de Stadt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R J van de Stadt","raw_affiliation_strings":["Jan van Breemen Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jan van Breemen Institute, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090739507","display_name":"Dirkjan van Schaardenburg","orcid":"https://orcid.org/0000-0003-4006-3762","observed_orcids":["https://orcid.org/0000-0003-4006-3762"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D van Schaardenburg","raw_affiliation_strings":["Jan van Breemen Institute, Amsterdam, The Netherlands","VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jan van Breemen Institute, Amsterdam, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108476892","display_name":"Ben A. C. Dijkmans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"B A C Dijkmans","raw_affiliation_strings":["Jan van Breemen Institute, Amsterdam, The Netherlands","VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jan van Breemen Institute, Amsterdam, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075695885","display_name":"Willem Frederik Lems","orcid":"https://orcid.org/0000-0002-6885-3953","observed_orcids":["https://orcid.org/0000-0002-6885-3953"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W F Lems","raw_affiliation_strings":["VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067384016","display_name":"Michael Twahier Nurmohamed","orcid":"https://orcid.org/0000-0002-6274-1934","observed_orcids":["https://orcid.org/0000-0002-6274-1934"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M T Nurmohamed","raw_affiliation_strings":["Jan van Breemen Institute, Amsterdam, The Netherlands","VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jan van Breemen Institute, Amsterdam, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112036494","display_name":"Lucien A. Aarden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"L Aarden","raw_affiliation_strings":["Sanquin Research, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanquin Research, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110447951","display_name":"D\u00f6rte Hamann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D Hamann","raw_affiliation_strings":["Sanquin Diagnostic Services, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanquin Diagnostic Services, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007969949"],"corresponding_institution_ids":["https://openalex.org/I3020210244"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":1.4131,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":{"value":0.82033583,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"68","issue":"4","first_page":"558","last_page":"563"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9440000057220459},{"id":"https://openalex.org/keywords/anti-citrullinated-protein-antibodies","display_name":"anti-citrullinated protein antibodies","score":0.9890000224113464},{"id":"https://openalex.org/keywords/igg4","display_name":"IgG4","score":0.9049999713897705},{"id":"https://openalex.org/keywords/igg1","display_name":"IgG1","score":0.8259999752044678},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.765999972820282},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.5870000123977661},{"id":"https://openalex.org/keywords/chronic-antigen-stimulation","display_name":"chronic antigenic stimulation","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9366801977157593},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.8294576406478882},{"id":"https://openalex.org/C2776232647","wikidata":"https://www.wikidata.org/wiki/Q702883","display_name":"Rheumatoid factor","level":3,"score":0.6953691244125366},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.648580014705658},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5232852101325989},{"id":"https://openalex.org/C144745244","wikidata":"https://www.wikidata.org/wiki/Q4927286","display_name":"Blocking (statistics)","level":2,"score":0.4630209803581238},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.4355343282222748},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.4188550114631653},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29904523491859436},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":13,"locations":[{"id":"doi:10.1136/ard.2008.088401","doi":"https://doi.org/10.1136/ard.2008.088401","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.2008.088401","pdf_url":"https://ard.bmj.com/content/annrheumdis/68/4/558.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmid:18445623","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18445623","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"Comparative Study"},{"id":"pmh:oai:dare.uva.nl:openaire/3837baea-3cdc-4e16-bca8-b1a34dbb2dd1","doi":null,"is_oa":true,"landing_page_url":"https://handle.uba.uva.nl/personal/pure/en/publications/preferential-decrease-in-igg4-anticitrullinated-protein-antibodies-during-treatment-with-tumour-necrosis-factor-blocking-agents-in-patients-with-rheumatoid-arthritis(3837baea-3cdc-4e16-bca8-b1a34dbb2dd1).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306400088","display_name":"UvA-DARE (University of Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I887064364","host_organization_name":"University of Amsterdam","host_organization_lineage":["https://openalex.org/I887064364"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bos, W H, Bartelds, G M, Vis, M, van der Horst, A R, Wolbink, G J, van de Stadt, R J, van Schaardenburg, D, Dijkmans, B A C, Lems, W F, Nurmohamed, M T, Aarden, L & Hamann, D 2009, 'Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis', Annals of the Rheumatic Diseases, vol. 68, no. 4, pp. 558-563. https://doi.org/10.1136/ard.2008.088401","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/a6919c83-5570-4aad-a66b-303b2158c204","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/a6919c83-5570-4aad-a66b-303b2158c204","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bos, W H, Bartelds, G M, Vis, M, van der Horst, A R, Wolbink, G J, van de Stadt, R J, van Schaardenburg, D, Dijkmans, B A C, Lems, W F, Nurmohamed, M T, Aarden, L & Hamann, D 2009, 'Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis', Annals of the rheumatic diseases, vol. 68, no. 4, pp. 558-563. https://doi.org/10.1136/ard.2008.088401","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/3861fddf-afad-4afe-b941-3b8d61c7ff06","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/3861fddf-afad-4afe-b941-3b8d61c7ff06","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bos, W H, Bartelds, G M, Vis, M, Horst, A, Wolbink, G, van de Stadt, R J, van Schaardenburg, D, Dijkmans, B A C, Lems, W F, Nurmohamed, M T, Aarden, L & Hamann, D 2009, 'Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis', Annals of the Rheumatic Diseases, vol. 68, no. 4, pp. 558-563. https://doi.org/10.1136/ard.2008.088401","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/48a483d2-20f5-41a4-bdbc-e0050cb2260f","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/preferential-decrease-in-igg4-anticitrullinated-protein-antibodies-during-treatment-with-tumour-necrosis-factor-blocking-agents-in-patients-with-rheumatoid-arthritis(48a483d2-20f5-41a4-bdbc-e0050cb2260f).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the rheumatic diseases, 68(4), 558 - 563. BMJ Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dare.ubvu.vu.nl:1871/22376","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/22376","pdf_url":null,"source":{"id":"https://openalex.org/S4306400546","display_name":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"68","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:open-archive.highwire.org:annrheumdis:68/4/558","doi":null,"is_oa":false,"landing_page_url":"http://ard.bmj.com/cgi/content/short/68/4/558","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:open-archive.highwire.org:annrheumdis:ard.2008.088401v1","doi":null,"is_oa":false,"landing_page_url":"http://ard.bmj.com/cgi/content/short/ard.2008.088401v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:uvapub:oai:dare.uva.nl:publications/3837baea-3cdc-4e16-bca8-b1a34dbb2dd1","doi":null,"is_oa":true,"landing_page_url":"https://dare.uva.nl/personal/pure/en/publications/preferential-decrease-in-igg4-anticitrullinated-protein-antibodies-during-treatment-with-tumour-necrosis-factor-blocking-agents-in-patients-with-rheumatoid-arthritis(3837baea-3cdc-4e16-bca8-b1a34dbb2dd1).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the Rheumatic Diseases, 68(4), 558 - 563. BMJ Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu2:oai:dare.ubvu.vu.nl:1871/22376","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1871/22376","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the Rheumatic Diseases, 68(4), 558","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu:oai:research.vu.nl:publications/b459fa62-5e69-4def-ae46-031d7c7ae690","doi":null,"is_oa":true,"landing_page_url":"https://research.vu.nl/en/publications/b459fa62-5e69-4def-ae46-031d7c7ae690","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the Rheumatic Diseases, 68(4), 558 - 563","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/3861fddf-afad-4afe-b941-3b8d61c7ff06","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/3861fddf-afad-4afe-b941-3b8d61c7ff06","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the Rheumatic Diseases, 68(4), 558 - 563. BMJ Publishing Group","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1136/ard.2008.088401","doi":"https://doi.org/10.1136/ard.2008.088401","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.2008.088401","pdf_url":"https://ard.bmj.com/content/annrheumdis/68/4/558.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320331585","display_name":"Dutch Arthritis Association","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2168397227.pdf","grobid_xml":"https://content.openalex.org/works/W2168397227.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W91916387","https://openalex.org/W162184855","https://openalex.org/W1499124767","https://openalex.org/W1641557591","https://openalex.org/W1646831595","https://openalex.org/W1854514017","https://openalex.org/W1903165307","https://openalex.org/W1940316087","https://openalex.org/W1967211753","https://openalex.org/W1978651681","https://openalex.org/W1980024538","https://openalex.org/W1985380203","https://openalex.org/W2000905503","https://openalex.org/W2005284010","https://openalex.org/W2018573210","https://openalex.org/W2024988150","https://openalex.org/W2052543535","https://openalex.org/W2066961297","https://openalex.org/W2074391349","https://openalex.org/W2074438676","https://openalex.org/W2096153127","https://openalex.org/W2100736304","https://openalex.org/W2103021172","https://openalex.org/W2104854678","https://openalex.org/W2107005433","https://openalex.org/W2109578241","https://openalex.org/W2116042754","https://openalex.org/W2119046820","https://openalex.org/W2122176733","https://openalex.org/W2134714663","https://openalex.org/W2137052550","https://openalex.org/W2140857612","https://openalex.org/W2142862879","https://openalex.org/W2146722884","https://openalex.org/W2154084259","https://openalex.org/W2163824348","https://openalex.org/W2166544427","https://openalex.org/W4250776648"],"related_works":["https://openalex.org/W1998169827","https://openalex.org/W2338600934","https://openalex.org/W2140857612","https://openalex.org/W2154084259","https://openalex.org/W1854514017","https://openalex.org/W2189130768","https://openalex.org/W3040015640","https://openalex.org/W1940316087","https://openalex.org/W2332108695","https://openalex.org/W1968938577"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}